Comparison of the prognostic value of SPECT after nitrate administration and metabolic imaging by PET in patients with ischaemic left ventricular dysfunction

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 4, 2007, Pages 558-562

  Sorrentino, Anna Rita ^a   Acampa, Wanda ^a   Petretta, Mario ^a   Mainolfi, Ciro ^a   Salvatore, Marco ^a   Cuocolo, Alberto ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

LV dysfunction; PET imaging; Prognosis; SPECT imaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; ISOSORBIDE DINITRATE; TETROFOSMIN TC 99M;

ADULT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG UPTAKE; FEMALE; FOLLOW UP; HEART DEATH; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METABOLISM; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVASCULARIZATION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL; UNSTABLE ANGINA PECTORIS;

FEMALE; HUMANS; IMAGE ENHANCEMENT; ISOSORBIDE DINITRATE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33947212326     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0304-2     Document Type: Review

References (16)

1. Patterson RE, Pilcher WC. Assessing myocardial viability to help select patients for revascularization to improve left ventricular dysfunction due to coronary artery disease. Semin Thorac Cardiovasc Surg 1995;7:214-26.
2. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-8.
3. Travin MI, Bergmann SR. Assessment of myocardial viability. Semin Nucl Med 2005;35:2-16.
4. He ZX, Yang MF, Liu XJ, Shi RF, Gao RL, Hu SS, et al. Association of myocardial viability on nitrate-augmented technetium-99m hexakis-2- methoxylisobutyl isonitrile myocardial tomography and intermediate-term outcome in patients with prior myocardial infarction and left ventricular dysfunction. Am J Cardiol 2003;92:696-9.
5. He W, Acampa W, Mainolfi C, Menna F, Sorrentino AR, Petretta M, et al. Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic imaging by PET. J Nucl Cardiol 2003;10:599-606.
6. Cuocolo A, Petretta M, Nicolai E, Pace L, Bonaduce D, Salvatore M, et al. Successful coronary revascularization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging. Eur J Nucl Med 1998;25:60-8.
7. Acampa W, Cuocolo A, Petretta M, Bruno A, Castellani M, Finzi A, et al. Tetrofosmin imaging in the detection of myocardial viability in patients with previous myocardial infarction: comparison with sestamibi and Tl-201 scintigraphy. J Nucl Cardiol 2002;9:33-40.
8. 18F-fluorodeoxyglucose. Circulation 1991;83:26-37.
9. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
10. Fleiss JL. Statistical methods for rates and proportions, 2nd ed. New York, NY: Wesley and Sons; 1981, p. 217-225.
11. 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease. Eur J Nucl Med 1992;19:334-342.
12. 18F]fluorodeoxyglucose. Circulation 1994;89:578-87.
13. Sciagrà R, Pellegri M, Pupi A, Bolognese L, Bisi G, Carnovale V, et al. Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2000;36:739-45.
14. Desideri A, Cortigiani L, Christen AI, Coscarelli S, Gregori D, Zanco P, et al. The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 2005;46:1264-9.
15. Siebelink HM, Blanksma PK, Crijns HJ, Bax JJ, van Boven AJ, Kingma T, et al. No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol 2001;37:81-8.
16. Kaul S. Response of dysfunctional myocardium to dobutamine. The eyes see what the mind knows. J Am Coll Cardiol 1996;27:1608-11.